title: Leptin-cytokine crosstalk in breast cancer.
abstract: Despite accumulating evidence suggesting a positive correlation between leptin levels, obesity, post-menopause and breast cancer incidence, our current knowledge on the mechanisms involved in these relationships is still incomplete. Since the cloning of leptin in 1994 and its receptor (OB-R) 1 year later by Friedman's laboratory (Zhang et al., 1994) and Tartaglia et al. (Tartaglia et al., 1995), respectively, more than 22,000 papers related to leptin functions in several biological systems have been published (Pubmed, 2012). The ob gene product, leptin, is an important circulating signal for the regulation of body weight. Additionally, leptin plays critical roles in the regulation of glucose homeostasis, reproduction, growth and the immune response. Supporting evidence for leptin roles in cancer has been shown in more than 1000 published papers, with almost 300 papers related to breast cancer (Pubmed, 2012). Specific leptin-induced signaling pathways are involved in the increased levels of inflammatory, mitogenic and pro-angiogenic factors in breast cancer. In obesity, a mild inflammatory condition, deregulated secretion of proinflammatory cytokines and adipokines such as IL-1, IL-6, TNF-α and leptin from adipose tissue, inflammatory and cancer cells could contribute to the onset and progression of cancer. We used an in silico software program, Pathway Studio 9, and found 4587 references citing these various interactions. Functional crosstalk between leptin, IL-1 and Notch signaling (NILCO) found in breast cancer cells could represent the integration of developmental, proinflammatory and pro-angiogenic signals critical for leptin-induced breast cancer cell proliferation/migration, tumor angiogenesis and breast cancer stem cells (BCSCs). Remarkably, the inhibition of leptin signaling via leptin peptide receptor antagonists (LPrAs) significantly reduced the establishment and growth of syngeneic, xenograft and carcinogen-induced breast cancer and, simultaneously decreased the levels of VEGF/VEGFR2, IL-1 and Notch. Inhibition of leptin-cytokine crosstalk might serve as a preventative or adjuvant measure to target breast cancer, particularly in obese women. This review is intended to present an update analysis of leptin actions in breast cancer, highlighting its crosstalk to inflammatory cytokines and growth factors essential for tumor development, angiogenesis and potential role in BCSC.
authors.affiliation: Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, United States. Electronic address: gnewman@msm.edu.
authors.forename: Gale
authors.initials: G
authors.lastname: Newman
authors.affiliation: Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, United States. Electronic address: rgonzalez@msm.edu.
authors.forename: Ruben Rene
authors.initials: RR
authors.lastname: Gonzalez-Perez
mesh_terms: D001943:Breast Neoplasms / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D020738:Leptin / Q000378:metabolism*; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology; D054411:Receptors, Leptin / Q000378:metabolism
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D020738:Leptin; D054411:Receptors, Leptin
keywords: Breast cancer; Cytokines; Leptin; Leptin peptide receptor antagonist; NILCO; Obesity
references.citation: Science. 1999 Apr 30;284(5415):770-6
references.pmid: 10221902
references.citation: Clin Cancer Res. 2004 Jul 1;10(13):4325-31
references.pmid: 15240518
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14564-8
references.pmid: 8962092
references.citation: Endocrinology. 1998 May;139(5):2278-83
references.pmid: 9564834
references.citation: Endocr J. 2002 Jun;49(3):371-7
references.pmid: 12201223
references.citation: Breast Cancer Res Treat. 2012 May;133(1):11-21
references.pmid: 22057973
references.citation: Cell. 1995 Dec 29;83(7):1263-71
references.pmid: 8548812
references.citation: J Leukoc Biol. 2007 Aug;82(2):354-60
references.pmid: 17505023
references.citation: Nature. 1998 Aug 20;394(6695):790-3
references.pmid: 9723619
references.citation: Cancer Treat Rev. 2012 Nov;38(7):904-10
references.pmid: 22651903
references.citation: Nature. 1998 Jun 18;393(6686):684-8
references.pmid: 9641678
references.citation: Histopathology. 2008 Oct;53(4):484-7
references.pmid: 18983614
references.citation: PLoS Biol. 2009 Jun 2;7(6):e1000121
references.pmid: 19492080
references.citation: Biochem Pharmacol. 2012 Mar 1;83(5):661-70
references.pmid: 22197587
references.citation: Breast Cancer Res. 2008;10(6):R95
references.pmid: 19014637
references.citation: J Biol Chem. 2004 May 7;279(19):19908-15
references.pmid: 14985328
references.citation: Curr Immunol Rev. 2008 May 1;4(2):70-79
references.pmid: 20198122
references.citation: Semin Reprod Med. 2002 May;20(2):113-22
references.pmid: 12087496
references.citation: J Clin Endocrinol Metab. 1999 Jul;84(7):2270-4
references.pmid: 10404789
references.citation: Breast Cancer Res Treat. 2010 Oct;123(3):627-35
references.pmid: 20571870
references.citation: J Clin Endocrinol Metab. 1999 Jan;84(1):300-6
references.pmid: 9920099
references.citation: Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5889-92
references.pmid: 8392180
references.citation: J Leukoc Biol. 2000 Oct;68(4):437-46
references.pmid: 11037963
references.citation: Int J Gynecol Cancer. 2006;16 Suppl 2:556-9
references.pmid: 17010072
references.citation: J Mol Med (Berl). 2010 Jul;88(7):677-86
references.pmid: 20339829
references.citation: Cell. 2009 Nov 13;139(4):693-706
references.pmid: 19878981
references.citation: J Biol Chem. 1998 Dec 25;273(52):35245-9
references.pmid: 9857064
references.citation: N Engl J Med. 1997 Apr 10;336(15):1066-71
references.pmid: 9091804
references.citation: Mol Cell. 2012 Mar 30;45(6):777-89
references.pmid: 22364742
references.citation: Breast Cancer Res. 2009;11(3):R36
references.pmid: 19531256
references.citation: J Clin Oncol. 2010 Jan 20;28(3):509-18
references.pmid: 19949017
references.citation: J Clin Invest. 2007 Jan;117(1):175-84
references.pmid: 17200717
references.citation: Endocr Relat Cancer. 2011 Jul 01;18(4):413-28
references.pmid: 21555376
references.citation: Oncologist. 2006 Apr;11(4):397-408
references.pmid: 16614236
references.citation: Br J Cancer. 2011 Jan 4;104(1):128-37
references.pmid: 21139583
references.citation: J Biol Chem. 1997 Jun 27;272(26):16216-23
references.pmid: 9195922
references.citation: Am J Physiol. 1998 Jan;274(1):R204-8
references.pmid: 9458919
references.citation: Cell Signal. 2010 Sep;22(9):1350-62
references.pmid: 20466060
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6390-5
references.pmid: 11344271
references.citation: Cancer Cell. 2011 Feb 15;19(2):192-205
references.pmid: 21295524
references.citation: Blood. 2006 Mar 15;107(6):2223-33
references.pmid: 16291593
references.citation: FASEB J. 1998 Jan;12(1):57-65
references.pmid: 9438411
references.citation: Biochem J. 2006 Jan 1;393(Pt 1):7-20
references.pmid: 16336196
references.citation: J Cell Biol. 1992 Nov;119(3):629-41
references.pmid: 1383237
references.citation: Cell Biochem Biophys. 2012 Jan;62(1):153-9
references.pmid: 22081436
references.citation: Endocr Relat Cancer. 2011 Jul 11;18(4):491-503
references.pmid: 21636700
references.citation: FASEB J. 2002 Sep;16(11):1471-3
references.pmid: 12205052
references.citation: Anticancer Res. 1999 Mar-Apr;19(2B):1427-32
references.pmid: 10365118
references.citation: Nurs Res. 2008 Jan-Feb;57(1):51-8
references.pmid: 18091292
references.citation: Cell. 1996 Feb 9;84(3):491-5
references.pmid: 8608603
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8374-8
references.pmid: 8710878
references.citation: Mol Cell Biol. 1998 Apr;18(4):2077-88
references.pmid: 9528780
references.citation: Nature. 2002 Jan 17;415(6869):339-43
references.pmid: 11797013
references.citation: Oncol Rep. 1994 Nov;1(6):1185-7
references.pmid: 21607512
references.citation: Growth Factors. 2001;19(1):1-17
references.pmid: 11678206
references.citation: J Biol Chem. 2003 Aug 1;278(31):28668-76
references.pmid: 12734209
references.citation: PLoS One. 2011;6(6):e21467
references.pmid: 21731759
references.citation: J Immunol. 1998 Nov 1;161(9):4652-60
references.pmid: 9794394
references.citation: J Clin Invest. 2010 Feb;120(2):485-97
references.pmid: 20051626
references.citation: Cancer Res. 1996 Jul 1;56(13):3118-22
references.pmid: 8674070
references.citation: Oncol Rep. 2003 Jul-Aug;10(4):1011-7
references.pmid: 12792762
references.citation: Int J Oncol. 2003 Aug;23(2):269-84
references.pmid: 12851675
references.citation: Cancer Prev Res (Phila). 2012 Mar;5(3):414-22
references.pmid: 22246620
references.citation: J Clin Invest. 2007 Sep;117(9):2362-8
references.pmid: 17786229
references.citation: PLoS One. 2011 Mar 25;6(3):e18168
references.pmid: 21464945
references.citation: Clin Cancer Res. 2003 Oct 15;9(13):4877-83
references.pmid: 14581361
references.citation: Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2088-94
references.pmid: 16609020
references.citation: J Cell Biochem. 2009 Aug 15;107(6):1139-49
references.pmid: 19533666
references.citation: Am J Pathol. 2003 Dec;163(6):2531-41
references.pmid: 14633625
references.citation: Lancet Oncol. 2012 Nov;13(11):1141-51
references.pmid: 23084519
references.citation: Biochim Biophys Acta. 2010 Aug;1806(1):108-21
references.pmid: 20462514
references.citation: N Engl J Med. 2001 Jan 25;344(4):276-85
references.pmid: 11172156
references.citation: Circulation. 2002 Feb 19;105(7):804-9
references.pmid: 11854119
references.citation: J Clin Invest. 1997 Dec 1;100(11):2777-82
references.pmid: 9389742
references.citation: Biomed Pharmacother. 2013 Feb;67(1):22-30
references.pmid: 23199901
references.citation: Am J Physiol Cell Physiol. 2007 Nov;293(5):C1481-8
references.pmid: 17728393
references.citation: Curr Pharm Des. 2012;18(26):3831-52
references.pmid: 22632748
references.citation: Cancer Lett. 2013 Mar 1;330(1):57-66
references.pmid: 23200674
references.citation: Cancer Res. 2012 Oct 15;72(20):5188-97
references.pmid: 22836755
references.citation: Exp Biol Med (Maywood). 2004 Feb;229(2):182-93
references.pmid: 14734797
references.citation: Arthritis Rheum. 2002 Oct;46(10):2604-12
references.pmid: 12384918
references.citation: Am J Physiol Endocrinol Metab. 2001 May;280(5):E745-51
references.pmid: 11287357
references.citation: Cancer Res. 2011 Nov 15;71(22):6965-75
references.pmid: 21948958
references.citation: Endocrinology. 2001 Oct;142(10):4389-93
references.pmid: 11564702
references.citation: Science. 1998 Sep 11;281(5383):1683-6
references.pmid: 9733517
references.citation: Hum Reprod Update. 2000 May-Jun;6(3):290-300
references.pmid: 10874574
references.citation: J Allergy Clin Immunol. 2005 May;115(5):911-9; quiz 920
references.pmid: 15867843
references.citation: Cancer Res. 2007 Dec 1;67(23):11377-85
references.pmid: 18056465
references.citation: Diabetes. 2007 Jan;56(1):16-23
references.pmid: 17192460
references.citation: J Clin Endocrinol Metab. 1997 Sep;82(9):3084-6
references.pmid: 9284748
references.citation: Breast Cancer Res Treat. 2003 Feb;77(3):205-15
references.pmid: 12602920
references.citation: Clin Cancer Res. 2000 Aug;6(8):3282-9
references.pmid: 10955814
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2813-20
references.pmid: 18539959
references.citation: Diabetes. 1998 May;47(5):847-50
references.pmid: 9588462
references.citation: J Immunol. 2009 Oct 1;183(7):4169-75
references.pmid: 19767566
references.citation: Gene. 2009 Apr 15;435(1-2):36-44
references.pmid: 19393188
references.citation: Circ Res. 1998 Nov 16;83(10):1059-66
references.pmid: 9815153
references.citation: Clin Cancer Res. 2009 Mar 15;15(6):1845-7
references.pmid: 19276254
references.citation: Biochem Biophys Res Commun. 1998 Mar 6;244(1):30-4
references.pmid: 9514868
references.citation: Diabetes. 2002 Apr;51(4):1016-21
references.pmid: 11916920
references.citation: Cancer Res. 2011 Apr 1;71(7):2455-65
references.pmid: 21459803
references.citation: Br J Cancer. 2009 Sep;101 Suppl 1:S15-7
references.pmid: 19756001
references.citation: Lancet. 2001 Feb 17;357(9255):539-45
references.pmid: 11229684
references.citation: FASEB J. 2001 Dec;15(14):2565-71
references.pmid: 11726531
references.citation: Clin Cancer Res. 2006 Mar 1;12(5):1447-53
references.pmid: 16533767
references.citation: Biochim Biophys Acta. 2011 Apr;1815(2):197-213
references.pmid: 21193018
references.citation: J Clin Endocrinol Metab. 2000 Dec;85(12):4883-8
references.pmid: 11134157
references.citation: Biochim Biophys Acta. 2009 Apr;1792(4):380-91
references.pmid: 19254761
references.citation: Nature. 1994 Dec 1;372(6505):425-32
references.pmid: 7984236
references.citation: Nature. 1999 Oct 14;401(6754):713-7
references.pmid: 10537111
references.citation: J Biol Chem. 1999 Oct 15;274(42):30059-65
references.pmid: 10514492
references.citation: J Gastroenterol. 2008;43(7):509-18
references.pmid: 18648737
references.citation: Nat Rev Cancer. 2003 Oct;3(10):756-67
references.pmid: 14570040
references.citation: Cytokine Growth Factor Rev. 2006 Oct;17(5):325-37
references.pmid: 16931107
references.citation: J Exp Med. 1997 Jan 6;185(1):171-5
references.pmid: 8996253
references.citation: World J Stem Cells. 2010 Oct 26;2(5):103-13
references.pmid: 21607127
references.citation: Cancer Res. 2001 Dec 15;61(24):8851-8
references.pmid: 11751408
references.citation: Physiol Behav. 2004 Apr;81(2):223-41
references.pmid: 15159169
references.citation: Genes Dev. 2006 Aug 1;20(15):2096-109
references.pmid: 16847353
references.citation: Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):829-34
references.pmid: 22207628
references.citation: Cancer Res. 1988 Jan 15;48(2):246-53
references.pmid: 2825969
references.citation: Endocr Rev. 1997 Oct;18(5):701-15
references.pmid: 9331549
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2645-50
references.pmid: 12598651
references.citation: Oncol Rep. 2008 Apr;19(4):905-11
references.pmid: 18357374
references.citation: J Clin Endocrinol Metab. 1996 Sep;81(9):3424-7
references.pmid: 8784109
references.citation: Structure. 2012 Mar 7;20(3):487-97
references.pmid: 22405007
references.citation: Oncogene. 2009 Jul 30;28(30):2745-55
references.pmid: 19483720
references.citation: Cancer Invest. 2000;18(4):293-302
references.pmid: 10808364
references.citation: Domest Anim Endocrinol. 2002 May;22(3):145-54
references.pmid: 11934523
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):6735-41
references.pmid: 18980965
references.citation: Crit Rev Immunol. 1996;16(1):1-11
references.pmid: 8809470
references.citation: J Chemother. 2012 Dec;24(6):348-57
references.pmid: 23174100
references.citation: Biochim Biophys Acta. 2011 Jun;1807(6):664-78
references.pmid: 21111705
references.citation: Maturitas. 2000 May 29;35(2):175-9
references.pmid: 10924844
references.citation: J Biol Chem. 1997 May 16;272(20):12897-900
references.pmid: 9148892
references.citation: Biochim Biophys Acta. 2012 Apr;1825(2):207-22
references.pmid: 22289780
references.citation: Int J Obes (Lond). 2009 Jan;33(1):151-6
references.pmid: 18982006
references.citation: N Engl J Med. 2006 Jan 19;354(3):270-82
references.pmid: 16421368
references.citation: J Immunol. 2005 Jun 1;174(11):6820-8
references.pmid: 15905523
references.citation: Nat Med. 1997 Sep;3(9):1029-33
references.pmid: 9288733
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2796-801
references.pmid: 21825174
references.citation: Maturitas. 2010 May;66(1):33-8
references.pmid: 20181446
references.citation: N Engl J Med. 2003 Apr 24;348(17):1625-38
references.pmid: 12711737
references.citation: Cancer Res. 2011 Jan 15;71(2):614-24
references.pmid: 21224357
references.citation: Crit Rev Immunol. 2001;21(1-3):299-310
references.pmid: 11642612
references.citation: Clin Cancer Res. 2006 Feb 15;12(4):1088-96
references.pmid: 16489061
references.citation: Oncogene. 2008 Oct 16;27(47):6120-30
references.pmid: 18591932
references.citation: Mol Cell Biol. 2001 Sep;21(17):5925-34
references.pmid: 11486031
references.citation: N Engl J Med. 1999 Jun 10;340(23):1801-11
references.pmid: 10362825
references.citation: J Clin Invest. 2011 Oct;121(10):3804-9
references.pmid: 21965337
references.citation: Cancer Metastasis Rev. 2010 Dec;29(4):569-79
references.pmid: 20830504
references.citation: Oncogene. 2009 Jul 30;28(30):2710-22
references.pmid: 19483731
references.citation: Cancer Res Treat. 2009 Sep;41(3):155-63
references.pmid: 19809565
references.citation: Endocrine. 2003 Jul;21(2):185-95
references.pmid: 12897384
references.citation: Int J Cancer. 2008 Dec 15;123(12):2782-90
references.pmid: 18798554
references.citation: Cell Stem Cell. 2012 Dec 7;11(6):825-35
references.pmid: 23142520
references.citation: J Cancer. 2012;3:310-21
references.pmid: 22866165
references.citation: Epidemiol Rev. 1993;15(1):48-65
references.pmid: 8405212
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16158-63
references.pmid: 17911267
references.citation: Cancer Res. 2008 Jun 15;68(12):4919-27
references.pmid: 18559540
references.citation: Breast Cancer. 2000;7(3):181-6
references.pmid: 11029795
references.citation: Thromb Res. 2012 May;129(5):641-7
references.pmid: 21840575
references.citation: Am J Epidemiol. 2005 Jul 15;162(2):101-14
references.pmid: 15972940
references.citation: Biochem Biophys Res Commun. 2000 Aug 18;275(1):154-8
references.pmid: 10944457
references.citation: Clin Cancer Res. 2010 Apr 1;16(7):1979-87
references.pmid: 20332324
references.citation: Mol Oncol. 2007 Sep;1(2):138-43
references.pmid: 19383291
references.citation: PLoS One. 2011 Apr 18;6(4):e18823
references.pmid: 21533119
references.citation: PLoS One. 2012;7(11):e49047
references.pmid: 23145063
references.citation: J Biol Chem. 2006 Sep 8;281(36):26320-8
references.pmid: 16825198
references.citation: J Immunol. 2010 Feb 1;184(3):1630-41
references.pmid: 20026736